20VC OGs: SpaceX Valued at $800BN & Harvey Raises $160M at an $8BN Price | Airwallex Raises $330M and The Battle with Keith Rabois | Netflix Acquires Warner Brothers | IPO Market Predictions for 2026: Anthropic, Stripe, Databricks and SpaceX

The episode opens with a deep dive into SpaceX’s latest secondary sale, which pushes the company’s implied valuation to roughly $800 billion—about forty times its current revenue run‑rate. Hosts highlight how this figure reflects the lingering "Elon premium," a valuation lift that often skews private‑market pricing and makes direct public‑market comparisons tricky. By unpacking the math behind the deal, they illustrate why such lofty numbers can feel disconnected from traditional valuation metrics, especially when the underlying revenue growth is modest.

Shifting to the broader IPO outlook, the panel argues that 2026 could become a watershed year if a handful of mega‑unicorns—most notably Anthropic, Databricks, and possibly a public‑market debut for SpaceX—materialize. They calculate that combined market caps could return upwards of $700 billion to venture investors, a sizable slice of the roughly $2.9 trillion private‑market FMV. The conversation stresses that while these outsized exits can dominate returns, they also raise questions about the sustainability of private‑market pricing and the risk of a “down‑round” shock when public valuations finally meet reality.

Finally, the hosts contextualize the current climate within historical IPO cycles, noting that landmark listings like Facebook (2012) and Alibaba (2018) sparked market euphoria that lifted entire sectors. They warn that the same dynamic could repeat if AI‑driven firms such as Anthropic and Databricks time their offerings correctly, but also caution that a sudden deceleration in growth would erode the premium investors have come to expect. In sum, the discussion underscores that venture capital returns increasingly hinge on a few high‑profile exits, making the timing and pricing of these IPOs critical for the industry’s health.